Core Insights - The article discusses 14 quality stocks with the highest dividends, highlighting established blue-chip firms that are expected to perform well across various market conditions [1][2]. Group 1: Market Conditions and Quality Stocks - Fidelity portfolio managers emphasize the difficulty in predicting stock performance in uncertain market conditions, suggesting that higher-quality companies tend to perform better [2]. - Key characteristics of quality investing include strong brands, high barriers to entry, experienced management teams, and consistent, predictable earnings [2]. - The traditional distinction between blue-chip and growth stocks has evolved, with blue-chip companies no longer limited to consumer staples [3]. Group 2: Methodology for Stock Selection - The selection process involved screening companies with a market capitalization above $2 billion and identifying those with strong dividend histories, focusing on stocks with dividend yields above 3% as of March 17 [5]. - The final selection was limited to companies that had recently reported significant developments likely to influence investor sentiment [5]. Group 3: Company-Specific Insights - Consolidated Edison, Inc. (NYSE:ED) has a dividend yield of 3.07% as of March 17, with recent price recommendations raised by JPMorgan and KeyBanc [7][8][9]. - The company announced a public offering of 7,000,000 common shares, with J.P. Morgan Securities LLC acting as the underwriter [10]. - Consolidated Edison is one of the largest investor-owned energy delivery companies in the U.S., providing a wide range of energy-related products and services [11]. Group 4: Medtronic plc Developments - Medtronic plc (NYSE:MDT) has a dividend yield of 3.22% as of March 17 and announced the acquisition of Scientia Vascular for approximately $550 million [12][13]. - The acquisition aims to enhance Medtronic's position in neurovascular procedures, improving access to complex brain blood vessels [13][14]. - The deal is expected to close in the first half of FY27 and is projected to be minimally dilutive to Medtronic's adjusted EPS in FY27, becoming accretive thereafter [14].

Core Viewpoint - TruBridge has postponed its fourth quarter and year-end 2025 earnings release and conference call to allow additional time for the completion of its year-end audit procedures [1] Company Summary - The earnings release was originally scheduled for March 16, 2026 [1] - A subsequent press release will confirm the new date for the earnings release of the fourth quarter and year-end [1]

Core Insights - TruBridge, Inc. has been recognized as one of Modern Healthcare's 2025 Best in Business, highlighting its dedication to rural and community healthcare [1] - The award signifies TruBridge's mission to assist healthcare providers in recouping revenue, reducing denials, and enhancing fiscal sustainability [1] - With a legacy of 45 years, TruBridge serves over 1,500 clients across the United States [1]